Now Reading: Fifth edition of MCADDI 2026 opens at University of Hyderabad on 25 October
-
01
Fifth edition of MCADDI 2026 opens at University of Hyderabad on 25 October
Fifth edition of MCADDI 2026 opens at University of Hyderabad on 25 October
The Story in Brief
The Federation of Asian Biotech Associations (FABA) will inaugurate the fifth edition of MCADDI 2026 (Medicinal Chemistry, Drug Discovery & Development India) at the University of Hyderabad on Sunday, 25 October 2026. The six-day programme, being held in Hyderabad for the first time, continues until 30 October and expects over 200 industry professionals and researchers.
The programme features 31 lectures covering the full drug discovery spectrum, from fundamental principles to clinical development, with an emphasis on real-world case studies. Scientists from global pharmaceutical companies including Pfizer, Bristol Myers Squibb, AbbVie and Novartis, as well as Indian firms Aragen, Aurigene and Sai Life Sciences, will speak. A dedicated artificial intelligence session will examine AI-based drug design.
Percy Carter of Pfizer will deliver the keynote address on advances in breast cancer therapy. The FABA Awards, including a Young Scientist Award of Rs 5 lakh and two Doctoral Awards of Rs 1 lakh each, will recognise biotechnology innovators. The CEO Conclave and awards ceremony are scheduled for 29 October at ITC Kohenur in Madhapur.
Indian Opinion Analysis
Both The Hindu and The Hans India cover MCADDI 2026 as a neutral, event-announcement story, leading with the same facts: the date, the host university, the number of lectures and the list of participating companies. The coverage is uniform wire-style reporting with no discernible slant. The Hans India adds a wider list of collaborating organisations and names the founding architect of MCADDI, while The Hindu provides more detail on the keynote speaker’s background. Neither source frames the event politically or ideologically. The balanced reading is straightforward: two outlets report the same event identically, with minor differences in supporting detail that do not change the story’s substance.
Coverage: 2 sources, 2 neutral
Sources (2): thehindu.com (neutral report), thehansindia.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
